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Abstract To analyze the function of TSP family members, we 
have expressed and purified mouse TSPl and TSP3 encoded by 
recombinant baculoviruses in Spodoptera frugiperda cells and 
compared these TSPs to mouse TSP2 prepared in a similar way. 
Yields of purified TSPl and TSP3 were 5-15 and 24 ug, 
respectively, per ml of conditioned medium. Mature, secreted 
mouse TSPl and TSP3 had the previously predicted NHz- 
terminal sequences of DHVKDTSFDLFSI, and SQDLQVID- 
LLT, respectively. Analysis by SDS-PAGE and rotary shadow- 
ing electron microscopy indicated that TSPl and TSP2 are 
disulilde bonded trimers whereas TSP3 is a disullide-bonded 
pentamer. Binding assays with 45Ca2+ as ligand and immobilized 
TSPl, TSP2 and TSP3 demonstrated that all three TSPs are 
calcium-binding proteins. These results are consistent with 
previous studies of TSP structure and demonstrate that 
Spodoptera cells process and secrete TSPs having the same 
subunit organizations and structure as the native vertebrate 
molecules. 
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1. Introduction 
Thrombospondins (TSPs) are a family of structurally re- 
lated modular glycoproteins [4]. To date, five thrombospon- 
dins have been identified in vertebrates. Thrombospondins are 
divided into two subgroups based on their primary structures, 
with TSPl and TSP2 in one group, and TSP3-TSPS in the 
other (review [4]). TSPS is also known as cartilage oligomeric 
matrix protein (COMP) [33,36]. 
Among TSPs, human platelet TSPl is the most well char- 
acterized. TSPl is a trimeric, secreted glycoprotein. Each 
TSPl subunit contains an NHz-terminal globular domain 
(the proline- and arginine-rich [PARP] module [3]), a domain 
that mediates trimerization, a procollagen module, three type 
1 (properdin) modules, three type 2 (EGF-like) modules, a 
series of type 3 (Ca 2+-binding) repeats, and a COOH-terminal 
globular domain (review [4]). TSPl and TSP2 have a similar 
domain organization [22,23]. Conceptual translational prod- 
ucts of the cDNAs of TSPs 3-5 reveal a different domain 
arrangement as compared to TSPs 1 and 2 [5,28,29,33,36,38]. 
In TSPs 3-5, the procollagen module and the type 1 modules 
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are missing, and four, instead of three, type 2 modules are 
found. The NHz-terminal PARP module is present in TSPs l- 
4. The Ca2+-binding repeats and the COOH-terminal globular 
region characteristic of the TSP family are well conserved in 
all TSPs. 
The patterns of expression of TSPl, TSP2 and TSP3 
mRNAs are distinct in tissues of embryonic and developed 
mice. Overall, TSPl expression is predominant over the other 
TSPs, except for the vasculature in early mouse embryonic 
development where TSP2 is prominently transcribed from 
days 10-18 [20]. Thereafter, constant expression of TSPl 
and TSP2 is observed in many organs and connective tissues. 
TSP3 expression is turned on later than that of TSPl or TSP2 
(from day 15 onward), and is mostly refined to gut, cartilage, 
lung and central nervous system [20,38]. Both TSPl and TSP2 
expression increase when mouse embryonal carcinoma cells 
are induced to differentiate into neurons, glial cells and fibro- 
blasts, but TSPl protein displays a fibrillar distribution pat- 
tern in the extracellular matrix whereas TSP2 is cell associated 
[30]. The different spatial and temporal expression patterns of 
TSPl, TSP2 and TSP3 suggest that the three TSPs may have 
unique tissue-specific functions. 
We have reported the expression of mouse TSP2 encoded 
by recombinant baculovirus [8]. To understand more about 
the structure and function of different TSPs, we have also 
expressed mouse TSPs 1 and 3 using the baculovirus system 
and compared the properties of the recombinant proteins to 
those determined for proteins purified from natural sources or 
inferred from conceptual sequences of cloned cDNAs. 
2. Materials and methods 
2.1. Production of recombinant viruses 
Procedures for generation of recombinant baculoviruses encoding 
mouse TSP2 [8] and mouse TSPl [9] have been previously described. 
A cDNA clone of mouse TSP3 (phage 10 clone) was a kind gift 
from Dr. Paul Bornstein, University of Washington, Seattle, WA. The 
TSP3 sequence encoded by this clone starts 41 bases 3’ to the start 
codon and spans the rest of the coding region [5]. Two complemen- 
tary oligonucleotides with terminal NcoI (5’) and BsaAI (3’) restric- 
tion sites were synthesized to fill in the missing 5’ coding region. The 
annealed oligonucleotides along with a restriction fragment of TSP3 
that spans the sequence from the BsaAI site at bp 231 to the EcoRI 
site of bv 1624 were cloned into the NcoI and EcoRI sites of vlasmid 
pAcSG2 (Pharmingen, San Diego, CA). The resulting construct was 
subjected to EcoRI and partial NcoI digestion yielding a fragment 
encoding the 5’-end of TSP3, i.e. from the initiator ATG to the EcoRI 
site at bp 1624. A restriction fragment that covered the 3’-end of the 
coding sequence, i.e. bps 1625-2935, was obtained by digestion of the 
original phage 10 clone with EcoRI and EsaBI. The 5’ and 3’ TSP3 
fragments were finally cloned into the NcoI and SmaI sites of 
pAcSG2. 
Recombinant virus encoding mouse TSP3 was generated using the 
BaculoGold transfection system (Pharmingen) with lipofectin (Gibco 
BRL, Gaithersburg, MD) according to the manufacturer’s instruc- 
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tions. After transfection, recombinant viruses were plaque purified 
once and then a high titer pass three virus pool was produced in 
serum-free SF900 II medium (Gibco BRL). 
37 
2.2. Production and purification of mouse TSPI, TSP2 and TSP3 
SF9 cells in serum-free SF 900 II medium at a density of 1.5 x 10’ 
cells/ml in a 500 ml spinner flask were infected with the respective 
recombinant viruses at a multiplicity of infection of 10. After 1 h at 
27°C with occasional agitation, cells were diluted to a final density of 
2.5 x lo6 cells/ml with medium containing 0.2% bovine serum albumin 
(Sigma, St. Louis, MO). The culture was incubated for approx. 48 h 
at 27°C before conditioned medium was harvested. The medium was 
made 2 mM in phenylmethylsulfonyl fluoride and cleared of cells and 
cellular debris by centrifugation at 1OOOxg for 15 min at 22°C. The 
cell-free conditioned medium was collected and used for purification 
within the same day. 
Human TSPl was purified from platelets [42]. Mouse TSP2 was 
purified by affinity chromatography on heparin-agarose as described 
[8]. Mouse TSPl and TSP3 were purified on heparin-agarose at room 
temperature as described for mouse TSP2. For TSPl, proteins were 
eluted with a step gradient of 300 mM, 450 mM and 2 M NaCl in 10 
mM Tris, pH 7.4, 0.3 mM CaCla, with the bulk of TSPl eluting at 450 
mM NaCl. For TSP3, proteins were eluted with a step gradient of 
275, 400 and 600 mM NaCl in 10 mM Tris, pH 7.4, 0.3 mM CaCls, 
with the majority of TSP3 molecules being present in the 275 and 400 
mM NaCl fractions. All buffer solutions used in the purification of 
TSPs l-3 contained 0.3 mM CaCla. 
2.3. Polyacrylamide gel electrophoresis in sodium dodeeyl sulfate 
(SDS-PAGE) and immunoblotting 
Discontinuous SDS-PAGE was performed according to the method 
of Laemmli as described [42]. Proteins were detected by staining with 
Coomassie brilliant blue. For immunoblotting, proteins were trans- 
ferred to a nitrocellulose membrane (Schleicher and Schuell, Keene, 
NH) and detected by overnight incubation with specific antibodies. 
Polyclonal antibodies that had been raised against a gene 10 fusion 
protein (PET expression vector) containing residues 888200 of mouse 
TSP2, against a similar fusion protein containing residues 92-205 of 
mouse TSPl [23,35], and polyclonal antibodies to human TSP3 [38] 
were kindly provided by Dr. Vishva Dixit, University of Michigan, 
Ann Arbor, MI. Antisera were diluted 1:500 in 10 mM Tris, pH 7.4, 
150 mM NaCI, containing 0.05% Tween 20 and 1% bovine serum 
albumin. Bound antibodies were subsequently detected with horserad- 
ish peroxidase conjugated goat anti-rabbit IgG (Cappel, West Chester, 
PA). 
2.4. Amino acid sequencing 
Purified mouse TSPl (50 pg) was absorbed onto the polyvinylidene 
difluoride (PVDF) membrane of a ProSpin sample preparation car- 
tridge (Applied Biosystems, Foster City, CA) according to the man- 
ufacturer’s instructions. TSP3 (75 ug) was separated by SDS-PAGE 
and transferred electrophoretically to a PVDF membrane. Protein was 
visualized by staining with Ponceau S, and the band corresponding to 
TSP3 was cut out, rinsed with HaO, and dried under nitrogen. The 
NHs-terminal protein sequences were determined by Edman degrada- 
tion performed at the Protein Sequence and Peptide Synthesis Facility 
at the Biotechnology Center of the University of Wisconsin using an 
automated Model 477A Liquid Pulse Sequencer and Model 475A Gas 
Phase Sequencer with on-line Model 120A PTH Analyzer and Model 
610A Data Analysis System (Applied Biosystems). 
2.5. Rotary shadowing electron microscopy 
Purified TSPllTSP3 were diluted in 10 mM Tris, pH 7.4, 0.3 mM 
CaCla to obtain a final NaCl concentration of 150 mM and loaded 
onto 0.6 ml heparin agarose columns. Columns were washed with 0.1 
M ammonium bicarbonate and bound TSP molecules eluted with 1 M 
ammonium bicarbonate. Rotary shadowing was perfomed in a Balzers 
BAF400K system as described [14]. Briefly, equal volumes of the 
protein samples and 80% glycerol were mixed and sprayed onto 
freshly cleaved mica pieces. Rotary shadowing with platinum was 
performed at an angle of 7’ to a thickness of 2.5 nm. Replicas of 
the TSP molecules were examined in a transmission electron micro- 
scope at an accelerating voltage of 80 kV and pictures were taken at a 
magnification of 73 000 X 
2.6. Dot-blot calcium-binding assay 
Purified TSPs were diluted to approx. 20 pg/ml in TBS (10 mM 
Tris, pH 7.4, 150 mM NaCl) containing 1 mM CaCls and 500, 250 or 
100 @/well blotted onto a nitrocellulose membrane by filtration using 
a Minifold dot-blot apparatus (Schleicher and Schuell). The mem- 
brane was subsequently washed three times with TBS containing 
1 mM CaCla and then overlaid with TBS containing 1 mM CaCla 
and 1 pCi/ml 45CaC1s for 1 h at room temperature. After incubation, 
the membrane was washed twice for 2.5 min each with 50% ethanol, 
and air dried. Bound radioactivity was quantified by phosphorima- 
ging. After collecting data on bound radioactivity, protein adsorbed 
to the nitrocellulose membrane was stained with Amido black. The 
membrane was made transparent with decahydronaphthalene (Sigma) 
and the amount of protein bound in each well was quantified by 
scanning with a GS 300 Transmittance/Reflectance Scanning Densi- 
tometer (Hoefer, San Francisco, CA) and normalized to a concentra- 
tion series of human TSPl adsorbed onto the same membrane. 
3. Results 
Spodoptera frugiperdu cells grown in serum-free medium 
were used to express full length mouse TSPl and TSP3. In 
the construction of the replacement vectors, excess 5’ untrans- 
lated sequences were removed from the TSP cDNAs because 
it has been suggested that these sequences might interfere with 
protein expression [34]. Polyclonal antibodies against the he- 
parin-binding domain of mouse TSPl specifically recognized 
on immunoblots a band migrating in SDS-PAGE at approxi- 
mately the size expected for TSPl when conditioned medium 
from cells expressing mouse TSPl was analyzed (data not 
shown). Anti-TSP3 antibodies specifically detected a N 150 
kDa band on immunoblots after SDS-PAGE separation of 
conditioned medium of cells infected with recombinant mouse 
TSP3 virus under reducing conditions (data not shown). The 
size of about 150 kDa is consistent with that previously re- 
ported for mouse TSP3 expressed in 293 cells [38]. Purification 
of recombinant TSPs by affinity chromatography on heparin 
(Fig. 1) yielded 5515 and 224 @ml conditioned medium for 
mouse TSPl and TSP3, respectively. 
Occasionally, the TSPs produced seemed to be heteroge- 
neous, as indicated by the presence of a weakly staining smear 
under the major TSP band on immunoblots (data not shown). 
The heterogeneity represented only a small portion of the 
purified TSP molecules as judged from protein staining of 
SDS-PAGE gels (not detectable, see Fig. 1) and rotary sha- 
dowing electron microscopy (see below). Because no hetero- 
geneity could be detected with antibodies to the NHs-terminal 
PARP domain in immunoblots of trypsin digests of recombi- 
nant mouse TSP2 [S], we believe that the heterogeneity results 
from a random termination of polypeptide elongation. Alter- 
natively, the type l-3 repeat regions may randomly misfold 
and become targets for endo- and exo-proteinases. Such 
events could be due to the shutdown of the cellular quality 
control machinery of insect cells at a very late stage of virus 
infection [34]. 
NHz-terminal amino acid sequence analysis of purified 
mouse TSPl gave the sequence NRIPESGGXNGVFDIFELI, 
indicating that processed, mature mouse TSPl starts with Asn 
at position 19 [23]. This is in agreement with the NHz-term- 
inal amino acid sequence of human platelet TSPl [15,40], and 
Von Heijne’s prediction of a signal sequence cleavage site 
[43]. Mouse TSP3 had an NHs-terminal sequence of 
XQDLQVIXLXT. This sequence conforms to the site of pre- 
dicted signal peptide cleavage between Gly-21 and Ser-22 
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Fig. 1. SDS-PAGE analysis of recombinant mouse TSPs. (A) Puri- 
fied TSPl (l), TSP2 (2) and TSP3 (3) were separated on a 3.5% 
non-reducing (NR) or a 7% reducing (R) SDS-polyacrylamide separ- 
ating gel. The molecular mass markers are indicated on the left and 
are: For non-reducing conditions (NR): fibronectin ladder [32] gen- 
erated by cross-linking fibronectin monomers with factor XIIIa (250 
kDa, monomer; 500 kDa, dimer; 750 kDa, trimer; and 1000 kDa, 
tetramer); 600 kDa, skeletal muscle nebulin; 200 kDa, myosin hea- 
vy chain. For reducing conditions (R): 250 kDa, fibronectin; 93 
kDa, phosphorylase A; 68 kDa, serum albumin; and 43 kDa, oval- 
bumin. (B) The sizes of recombinant mouse TSPs were estimated 
from SDS-PAGE under non-reducing conditions. Molecular weights 
(MW) of size markers (open circles) were plotted versus their mobi- 
lity (see A, NR). The mobility of TSPl (ml), TSP2 (m2) and TSP3 
(m3) is indicated (arrows). 
[5,38,44] to yield the NHs-terminal sequence SQDLQVIDLLT 
in the mature protein. 
SDS-PAGE analysis in 3.5 or 7% separating gels was used 
to assess the sizes of non-reduced and reduced mouse TSPs, 
respectively. Under reducing conditions, the subunit of TSPl 
migrated faster on SDS-PAGE than the subunit of TSP2 (Fig. 
lA), with an apparent size of 160 and 185 kDa, respectively. 
A similar difference in size has been observed between mouse 
TSPl and TSP2 secreted by transiently transfected human 293 
cells [35]. The size of reduced TSP3 monomer was 145 kDa 
(Fig. 1A). Plotting the logarithm of the molecular weights of 
standard proteins (see figure legend) versus mobility allowed 
us to estimate the sizes of non-reduced mouse TSPl-TSP3 
molecules to be approx. 420, 480 and 590 kDa, respectively 
(Fig. 1B). The ratios of sizes for the non-reduced over reduced 
forms of both TSPl and TSP2 are 2.6, suggesting that the 
mature molecules are homotrimers when considering that 
both TSPl and TSP2 are rich in intrachain disulfide bonds 
and are expected to be in relatively more compact form with 
faster mobility under non-reducing than under reducing con- 
ditions. For TSP3, the size ratio of the non-reduced to re- 
duced form is 4.1, suggesting a subunit composition larger 
than a trimer, presumably a pentamer. 
To explore further the quaternary structure and subunit 
composition of recombinant mouse TSPl, TSP2 and TSP3, 
rotary shadowing electron microscopy was performed. Well- 
mTSP1 
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mTSP3 
60 nm 
I (nm) mean+/-S.D. I I 
hTSP1 31.2 f 2.3 13.2 f 2.3 l(3) 3 
mTSP1 26.9 f 1.2 12.4 f 1.7 l(3) 3 
I mTSP2 30.0 f 1.3 13.6 f 0.9 1 (3) I 3 I 
mTSP3 14.6 f 1.7 11.1 f 0.9 1 5 
Fig. 2. Rotary shadowing electron microscopy of human TSPl puri- 
fied from platelets and recombinant mouse TSPl, TSP2 and TSP3 
expressed in insect cells. (A) A selection of images of representative 
particles in each protein preparation is shown. (B) Structural do- 
mains of TSP molecules (at least five molecules of each TSP gene 
product) were measured and the results are given as mean-+stand- 
ard deviation. For TSPl and TSPZ, the central globule could be 
resolved into three small globular domains in some molecules. 
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Fi, g. 3. Ca2+ binding of human TSPl purified from platelets and re- 
combinant mouse TSPl, TSP2 and TSP3 expressed in insect cells. 
10, 5, or 2 pg of human platelet TSPl (hTSPl), recombinant mouse 
TSP l-3 (mTSPl-3) or fibronectin (FN) was dot blotted in dupli- 
cate onto a nitrocellulose membrane and incubated with 45Ca2+. 
Ca2+ binding was visualized (shown result) and quantified by phos- 
phorimaging. The amount of protein bound to the membrane was 
subsequently determined as described in Section 2. When the ratio 
of bound 45Ca2f to protein adsorbed to the membrane was normal- 
ized to human TSPl in two separate experiments, the following 
average numbers were derived: mouse TSPl, 0.38; mouse TSP2, 
0.54; mouse TSP3, 0.27; and fibronectin, <O.lO. 
defined molecules consisting of globular- and rod-like do- 
mains were visible (Fig. 2). Molecules of mouse TSPl and 
TSP2 displayed a similar structure that is also consistent 
with images of human platelet TSPl reported previously 
[11,26] and replicated by us (Fig. 2A). Each molecule had 
three thin flexible regions, connected at one end, where each 
rod-like domain is attached to a small globular domain. The 
three small globular domains are close together, and on some 
of the replicas of the molecules, appeared as one big globule 
(Fig. 2A). The connecting strands on the more extended mo- 
lecules had a length of 31.2 f 0.9, 26.9 + 1.2 and 30.0 f 1.3 nm 
for human TSPl, mouse TSPl and mouse TSP2, respectively 
(Fig. 2B) (measurements are expressed as mean f S.D. and are 
not corrected for the thickness of the metal coat since the 
globular domains might be more heavily decorated than the 
thinner connecting regions). At the other end of each rod-like 
domain, a large globule can be seen with a size of about 12 
nm. Images of mouse TSP3 were distinctly different from 
those of TSPl or TSP2. Five globular domains appeared to 
be each connected by a thin connecting region to a central 
globule (Fig. 2A). The rod-like connecting domains had a 
length of 14.6 f 1.7 nm, and were shorter than those of 
TSPl or TSP2 (Fig. 2B), compatible with the fact that TSP3 
is missing the procollagen and all three type 1 modules, which 
form part of the connecting strand. 
The ability of the recombinant TSPs to bind Ca2+ was 
examined. In a ligand blot experiment where purified TSPs 
immobilized on a nitrocellulose membrane were incubated 
with 45Ca2f all TSPs, including human TSPl purified from 
platelets, an’d recombinant mouse TSPl, TSP2 and TSP3, 
bound Ca2+ (Fig. 3). When Ca 2+ binding of the recombinant 
mouse proteins was compared by phosphorimaging to human 
TSPl, which is known from titration studies to contain ap- 
prox. 11 Ca2+-binding sites per subunit [31], the signals of 
39 
bound 45Ca2+ for mouse TSPs 1, 2 or 3 were 25-55% as 
intense as that detected with an equivalent amount of human 
TSPl . Only background levels of radioactivity were associated 
with an equivalent amount of immobilized fibronectin. 
4. Discussion 
In this paper, we report the expression and characterization 
of mouse TSPl and TSP3 and compare these TSPs to the 
previously expressed mouse TSP2 [8]. Insect cells were able 
to synthesize and then assemble and secrete TSPs appropri- 
ately as trimers (TSPl and TSP2) or pentamers (TSP3). The 
capability to produce large quantities of different TSPs, all 
expressed in the same system, should enable well-controlled 
comparative structural and functional studies of these mole- 
cules. The system should also be well-suited for expression of 
TSPS and thus facilitate the study of the pathogenesis of 
pseudo-chondrodysplasia [6,18]. 
The fact that TSPs l-3 bind to heparin agarose provided a 
convenient and consistent method for purification. Heparin 
binding was expected for mouse TSPl because of its sequence 
homology to human TSPl, which is known to bind heparin 
through its NHz-terminal PARP module [12,24,40]. Mouse 
TSP2 has previously been shown to bind heparin [8,35]. De- 
spite the fact that the TSP3 NHz-terminal PARP module 
lacks the known heparin binding sequences [27], and that 
TSP3 also lacks the type 1 modules that possess heparin bind- 
ing sequences [7,16], mouse TSP3 bound to heparin-agarose. 
This result is consistent with reports by other laboratories 
showing that both TSP3 and TSP4 bind heparin [17,29,39] 
while TSPS, which lacks the full PARP module, does not 
[17,19]. It is not yet clear what sequences in TSP3 or TSP4 
are responsible for the heparin binding property. However, 
the fact that NHz-terminally truncated TSP4 molecules, miss- 
ing the PARP module, isolated from bovine tendon do not 
bind heparin suggests that heparin binding is mediated by the 
PARP module also in TSP4 [17]. Given that fact that some of 
the cell adhesion properties of TSPl and TSP2 are mediated 
via the heparin binding modules, it will be interesting to test if 
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Fig. 4. Sequence alignment of the coiled-coil regions of TSPs. Se- 
quences of mouse TSPl and mouse TSP2 (A), and mouse TSP3, hu- 
man TSP4 and rat TSPSKOMP (B) are aligned, with the a and d 
positions of the presumptive heptad repeats indicated. Identical resi- 
dues are indicated by vertical lines and conservative replacements by 
dots. 
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Fig. 5. Helical wheel presentation of the coiled-coil structure of one 
subunit of TSPs. Sequences of the presumptive coiled-coil regions of 
mouse TSPl (1) and mouse TSP2 (2) (A), or mouse TSP3 (3) hu- 
man TSP4 (4) and rat TSPSKOMP (5) (B) are depicted in helical 
wheel forms, with the heptad repeat positions indicated (a-g). Resi- 
dues from different TSPs appearing at the same position of the 
same o-helix turn (compare to Fig. 4) are placed side by side with 
each other. NHa-termini of the sequences are placed at the inside of 
the wheels. Apolar residues are boxed. Arrows point to the cysteines 
forming interchain disulfide bonds. In the coiled-coil structure, three 
subunits (for TSPl and TSP2) or five subunits (for TSPs 3-5) will 
be close to each other with position a from one helix interacting 
with position d from the next one, thereby forming the hydrophobic 
core. 
TSP3 can mediate cell adhesion, and, if it can, whether adhe- 
sion is mediated through heparan sulfate proteoglycans as for 
human TSPl [21] and mouse TSP2 [S]. 
When comparing TSP gene products, the sequence identity 
increases from the NHs-terminus to the COOH-terminus [4]. 
All TSP family members identified to date have a series of 
Ca2+-binding loops formed by the type 3 repeats located next 
to the COOH-terminal globe. TSPl purified from human pla- 
telets binds about 11 Ca2+ ions per subunit with an affinity of 
20-120 mM [25,31]. CISP (the presumed bovine form of 
TSP2) purified from adrenocortical cells, also binds Ca2+ 
[37]. We demonstrate that recombinant mouse TSPl, TSP2, 
and TSP3 expressed in insect cells are all Ca2+-binding pro- 
teins. The semi-quantitative method used indicates that com- 
parable amounts of Ca2+ are bound by the recombinant 
mouse proteins, a result consistent with the high conservation 
of the multiple aspartate-rich Ca’+-binding motifs. 
Synthesis, assembly, and secretion of large multi-subunit 
proteins present a special challenge to cells. Given the effi- 
ciency of assembly of mouse TSPs in heterologous insect cells, 
there must be a strong force behind the multimerization pro- 
cess. The sequences around the proposed multimerization re- 
gion in mouse TSPl and TSP2 (Fig. 4A), and mouse TSP3 in 
comparison to human TSP4 and rat COMP/TSPS (Fig. 4B) 
are shown. These alignments show a striking pattern of hep- 
tad repeats that are the building units of coiled-coil structures, 
with positions a and d being apolar residues and other posi- 
tions polar or charged residues [lo]. A drawing in a helical 
wheel form shows that when arranged in an a-helix, the a and 
d residues are mostly hydrophobic residues facing one side of 
the helix (Fig. 5). Hydrophobic interactions between residues 
a and d are suggested to be a prerequisite for coiled-coil for- 
mation [2,10]. The Cys residues involved in the interchain 
disulfides are located on either a (for TSPs 1 and 2) or d 
(TSPs 335) positions and the residue next to it, i.e. residue e 
(TSPs 1 and 2) or g (TSPs 3-5). These Cys residues are lo- 
cated at either the start (for TSPs 1 and 2) or the end (TSPs 
335) of the coils. As with laminins [l], this arrangement could 
help to lock and strengthen the coiled-coil structure. Charged 
side arms are proposed to interact with each other through 
ionic interactions and help to determine the specificity and 
subunit composition [2,10]. When comparing the residues im- 
mediately next to the hydrophobic center of the coiled-coil, 
position g is enriched in negatively charged residues for both 
groups. Compared to the residues in position e of the TSPs 1 
and 2, TSPs 3-5 are enriched in highly positively charged 
residues. These may participate in ionic interactions that favor 
the pentameric arrangement of TSPs 335. 
The scenario for TSPs, then, is one in which the NHs-termi- 
nal portions through the end of the heptad repeat regions are 
assembled co-translationally into trimers or pentamers, fol- 
lowed by sequential folding of the more COOH-terminal 
modules. Evidence for human TSPl that trimerization is 
mediated through the coiled-coil structure that in turn can 
be stabilized by the interchain disulfide bonds [41] comes 
from studies of TSPl truncated at residue 381, TSP381. 
TSP381 formed heterotrimers with endogenously produced 
TSP when transfected into COS cells [41]. Mutated TSP381 
in which the cysteines forming interchain disulfides (Cys-270 
and Cys-274) were changed to glycines were secreted from 
COS cells, suggesting appropriate folding by non-covalent in- 
teraction of the coiled-coil region [41]. TSP4 purified from 
tendon [17] or expressed in NIH 3T3 cells [29] and TSP3 
expressed in mammalian 293 cells [39] are pentamers. Similar 
to TSP381, when Cys-245 and Cys-248 in the multimerization 
region of TSP3 were mutated to serines, TSP3 was secreted 
but migrated as a monomer on SDS-PAGE without reduction 
[39]. A recombinant fragment representing the homologous 
multimerization region of TSPSKOMP was shown to form 
a pentameric coiled-coil structure by crystallographic analysis 
[13], although the refined structure has not yet been reported. 
The ability of the oxidized and reduced recombinant TSPSI 
H. Chen et al.IFEBS Letters 387 (1996) 3641 
COMP fragment to form pentamers is strong evidence that 
the heptad repeat region contains the information needed for 
correct multimer formation. 
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